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tCr signal strength alters t–dC 
activation and interaction times and 
directs the outcome of differentiation
Nicholas van Panhuys*
Division of Experimental Biology, Sidra Medical and Research Center, Doha, Qatar
The ability of CD4+ T cells to differentiate into effector subsets underpins their ability to 
shape the immune response and mediate host protection. During T cell receptor-induced 
activation of CD4+ T cells, both the quality and quantity of specific activatory peptide/
MHC ligands have been shown to control the polarization of naive CD4+ T cells in addi-
tion to co-stimulatory and cytokine-based signals. Recently, advances in two- photon 
microscopy and tetramer-based cell tracking methods have allowed investigators to 
greatly extend the study of the role of TCR signaling in effector differentiation under 
in vivo conditions. In this review, we consider data from recent in vivo studies analyzing 
the role of TCR signal strength in controlling the outcome of CD4+ T cell differentiation 
and discuss the role of TCR in controlling the critical nature of CD4+ T cell interactions 
with dendritic cells during activation. We further propose a model whereby TCR signal 
strength controls the temporal aspects of T–DC interactions and the implications for this 
in mediating the downstream signaling events, which influence the transcriptional and 
epigenetic regulation of effector differentiation.
Keywords: tCr, differentiation, t cell, signal strength, cytokine
introdUCtion
CD4+ T cells constitute a key population in the adaptive arm of the immune response, due to their 
ability to differentiate into various distinct effector populations such as Th1, Th2, Th17, T follicular 
helper (Tfh) cells, and induced regulatory (iTreg) T cells, which help to orchestrate host defense 
against various classes of pathogens (1, 2). The differentiation of naive CD4+ T cells into polarized 
effectors has been studied extensively, and two alternative mechanisms of cell fate control have been 
described. The predominant view espoused by the field is that following the activation of a CD4+ T 
cell by an antigen-presenting cell (APC) displaying cognate peptide in the context of MHCII CD4+ 
T cells differentiate into highly specialized subsets according to the cytokine milieu present during 
activation and division (1, 3, 4). However, in addition to this qualitative/cytokine-based model of dif-
ferentiation, the literature also contains clear evidence for a quantitative mechanism that controls cell 
fate decisions. Quantitative models indicate that upon activation, CD4+ T cells are able to determine 
the strength of TCR signaling in terms of both the antigen load and quality of peptide presented, 
and in combination with co-stimulatory molecules, CD4+ T cells perform a cellular calculus to 
determine activatory signal strength. T-helper cells then use this qualitative signaling information 
to determine which program of differentiation to engage in (5).
This review aims to discuss the evidence that supports the strength of signal-based mechanisms 
for inducing differentiation in parallel with qualitative mechanisms and argues that TCR signaling 
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dynamics include a temporal component that regulates the inter-
actions between APC and CD4+ T cells, which explains much of 
the observed qualitative and quantitative phenomena previously 
described.
QUaLitatiVe MeCHanisMs oF 
t-HeLper CeLL diFFerentiation
Cytokine-based models indicate that CD4+ T cell differentia-
tion is controlled by a qualitative signaling mechanism in which 
specific combinations of cytokines produced mainly by myeloid 
APCs (and also by non-hematopoietic tissue elements) induce a 
specific pathway of differentiation following antigen-dependent 
activation of CD4+ T cells. Following the activation of APC by 
pathogen-associated molecular patterns (PAMPs), APCs begin to 
upregulate the levels of both MHCII and co-activation molecules 
allowing for the activation of CD4+ T cells in an antigen-specific 
manner. PAMPs additionally induce the production of specific 
cytokines by activated APCs, which have been shown to induce 
the differentiation of specialized T-helper populations (6). 
Cytokines have been shown to directly induce the differentiation 
of T-helper subsets through binding to specific receptors on the 
surface of CD4+ T cells, the activation of specific patterns of 
JAKs and STATs, which then translocate to the nucleus, and the 
upregulation of master transcription factors that are essential for 
the determination and maintenance of cell lineage and control-
ling downstream effector functions (1, 7). Th1 cells are induced 
in response to infection with bacterial or viral pathogens and are 
also a hallmark of autoimmune disease. Th1 differentiation can 
be induced following exposure to IFNγ (8) or IL-12 (9) during 
activation and is characterized by the expression of the master 
regulator of transcription Tbet (10) and production of the effec-
tor cytokine IFNγ. Th2 differentiation occurs following infection 
with helminthic parasites and is also responsible for much of 
the pathology associated with asthmatic and allergic responses. 
Th2 cells are characterized by the upregulation of GATA3 (11) 
following differentiation and the ability to produce IL-4, -5, and/
or -13 upon re-stimulation. While Th2 differentiation has classi-
cally been believed to be driven by IL-4 (12), several studies have 
indicated that IL-4 is not required for Th2 differentiation under 
in vivo conditions (13, 14). Additionally, cytokines such as IL-25 
and IL-33 and TSLP have also been implicated to be involved 
in Th2 differentiation; however, these factors were not found to 
be required for the induction of differentiation (15). Thus, it has 
proved difficult to determine a specific qualitative cytokine signal 
responsible for Th2 differentiation under in vivo conditions, and 
it has been suggested that Th2 induction may occur through a 
default or endogenous pathway (16). Th17 cells are believed to 
play a role in defending against fungal pathogens and have also 
been found to play a significant role in several autoimmune dis-
eases. The Th17 lineage is characterized by the expression of the 
transcription factor RORγt and by the expression of the cytokines 
IL-17, -21, and/or -22 (17). Tfh cells perform a specialized func-
tion in that after differentiation, they localize to the B cell follicle 
and are critical for providing B cell help, by inducing B cell affinity 
maturation, differentiation, and promoting the class switching of 
B cell immunoglobulin isotype expression. They are generally 
characterized by IL-21 expression along with the transcriptional 
repressor Bcl-6 and the surface receptors CXCR5 and PD-1 (2). 
iTreg cells are functionally distinct from other groups of T-helper 
cells as they play a key role in the immune response by dampen-
ing down excessive CD4+ T cell activation and controlling the 
extent of inflammation. While iTreg cells are characterized by the 
expression of the transcription factor Foxp3 and production of 
regulatory cytokines such as TGFβ and Il-10, these factors are 
also present in naturally occurring or thymically derived Tregs 
(nTreg), making it problematic to distinguish these two subsets 
under in vivo conditions (18).
These studies form a large body of compelling evidence indicat-
ing that the cytokine milieu represents a highly deterministic cellu-
lar cue during the polarization process. However, it should be noted 
that cell fate decisions occur due to a number of factors, and as the 
majority of qualitative/cytokine-based studies have been conducted 
at single antigen concentrations in vitro or in vivo, the quantitative/
TCR signal strength-based component is generally not considered 
giving the appearance that cytokines dominate. However, in prac-
tice, this conclusion requires a more explicit analysis to assess the 
relationship and possible hierarchical and temporal dominance of 
qualitative vs. quantitative aspects of control.
tCr siGnaL strenGtH (antiGeniC 
QUantity/QUaLity) direCts Cd4+ t 
CeLL diFFerentiation
The most widely characterized example of TCR signal strength 
directly contributing to the alternate differentiation of CD4+ T 
cells has been studied looking at the comparative differences in 
Th1 vs. Th2 induction. It has long been established that under 
in vitro conditions, a strong TCR signal leads to a predominance 
of Th1 differentiation, whereas weak TCR signaling leads to Th2 
differentiation (19, 20). Early studies using an altered peptide 
ligand (APL) model system compared stimulation of TCR trans-
genic (Tg) CD4+ T cells with either the native Moth Cytochrome 
C (MCC) peptide or the K99 peptide, which has a significantly 
weaker affinity for the Tg TCR. When APCs were loaded with an 
equivalent quantity of antigen, those stimulated with the higher 
affinity MCC peptide displayed a striking tendency to differenti-
ate into Th1 cells, whereas those stimulated with the weaker K99 
peptide differentiated to the Th2 phenotype (19, 21–23). The 
capacity of APCs to induce TCR signaling can be modulated by 
both the affinity of the peptide:MHCII (pMHCII) complex for a 
specific TCR and the quantity of pMHCII present on the surface 
of the APC. Parallel studies examining the effects of peptide load 
on the differentiation CD4+ T cells revealed that stimulation with 
APCs loaded with a high dose of peptide led to the induction 
of Th1 cells, whereas stimulation with a low dose of peptide 
resulted in the differentiation of Th2 cells (20, 24). Together, these 
results show that altering the initial TCR stimulus received by 
naive CD4+ T cells, by either pMHC affinity or density, leads to 
a divergent outcome in terms of the end point of differentiation, 
with strong TCR signaling leading to Th1 differentiation and 
weak TCR signaling leading to Th2 differentiation (Figure 1).
FiGUre 1 | ability of dCs to stimulate tCr signaling controls the 
activation potential of Cd4+ t cells. DC priming of CD4+ T cells is 
dependent on the overall signal strength imparted by specific DC, where TCR 
signal strength = [peptide] × Ka of pMHCII. DC signaling capacity must be 
fitted to a distribution profile at the population level due to multiple factors, 
including expression levels of MHCII and co-stimulatory molecules, peptide 
loading efficiency, DC morphology, and availability of sites for interaction in a 
complex 3D environment. Here, DC lacking cognate peptide fail to stimulate 
a response from T cells (dotted line), whereas at low levels of signal strength, 
DC induce a complex response inducing anergy and Th2 and Th1 
differentiation, with a predominant skewing toward TH1 differentiation 
(dashed line). When strong signals are present, the response is skewed 
toward TH1 differentiation with both Th2 differentiation and activation-
induced cell death (AICD) also occurring (solid line).
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Recent studies utilizing two-photon intravital microscopy and 
tetramer-based cell tracking methods have allowed investigators 
to greatly extend the study of the role of TCR signaling in effector 
differentiation under in vivo conditions. While the earlier stud-
ies discussed above imply that modulation of antigenic quality 
or quantity leads to similar outcomes at comparable levels of 
TCR stimulation, studies into the in  vivo requirement for Treg 
generation by Gottschalk et al. (25, 26) indicate that TCR is able 
to differentiate between the two and that alteration of either of 
these components can affect the outcome of differentiation and/or 
survival, thus modulating the outcome of the immune response. 
Here, the induction of iTreg cell differentiation was assessed under 
in  vivo conditions following the i.v. injection of MCC peptide 
or an APL to induce the activation of 5C.C7 TCR Tg CD4+ T 
cells. By adjusting the dose of MCC or APL peptide injected to 
normalize for peptide potency, comparable levels of proliferation 
and Foxp3 expressing iTreg cells were induced. However, those 
iTreg cells induced following activation with low-affinity ligands 
were unable to persist in vivo, illustrating the ability of TCR to 
distinguish between the quality and quantity of cognate peptide 
being presented under in vivo conditions (25). It was additionally 
determined that while large quantities of a weak agonist peptide 
and small quantities of a strong agonist peptide can provide a 
compensatory outcome in terms of in  vivo proliferation, the 
stimulation of CD4+ T cells under these conditions led to diver-
gent outcomes in terms of the gene expression profile-induced 
downstream. Further, intravital microscopy revealed that more 
stable contacts between CD4+ T cells and APC were observed in 
the presence of a strong agonist peptide in comparison to a weak 
agonist peptide, irrespective of the dose used (26), indicating anti-
gen quality-dependent differences in T–DC interaction times may 
contribute to the observed divergence in gene expression profiles.
The differentiation of CD4+ T cells is influenced by TCR-
mediated, co-stimulatory molecule and cytokine-induced 
signaling, all of which are modulated following APC activation 
by PAMPS or adjuvant-associated molecular patterns. The rela-
tionship between these factors in determining the outcome of dif-
ferentiation is highly relevant. We recently addressed this issue by 
conducting a study utilizing the intravital imaging of CD4+ T cells 
interactions with DCs following their exposure to Th1- or Th2-
polarizing adjuvants (27). Using Ca2+ flux imaging, these studies 
revealed a close correlation between the strength of TCR-induced 
signaling and the length of interaction, with Th1 differentiation 
being induced following increased TCR-associated signaling 
and longer lengths of interaction time. Under these conditions, 
antigen concentration was found to dominate over adjuvant in 
controlling differentiation. At a fixed antigen concentration, 
adjuvants inducing Th1 differentiation operated by increasing the 
co-stimulatory molecule expression on stimulatory DCs, which 
has previously been shown to potentiate TCR-associated signal-
ing (28) and induce tighter T–DC interactions (29). However, by 
titrating the level of peptide used, we found that the concentra-
tion of antigen dominates the outcome of the response, such that, 
at high doses of antigen, CD4+ T cells primed with DC activated 
with Th2-polarizing adjuvants developed into Th1 cells and at 
low doses of antigen, Th2 differentiation predominated even after 
priming with DC activated in the presence of Th1-polarizing 
adjuvants. These responses showed a direct connection between 
alterations in Ca2+ signaling and interaction times, indicating 
that adjustments to TCR signal strength that affect interaction 
duration and signal accumulation can reverse the fate outcome, 
irrespective of the adjuvant used to treat the DC. These data imply 
that qualitative control of differentiation by cytokines reflects a 
secondary step in a developmental system in which the strength 
of initial T cell signaling regulates the capacity of the cells to 
respond to these mediators.
The majority of studies into the effects of TCR signal strength 
on CD4+ differentiation have relied upon the use of TCR Tg 
model systems; however, in order to more closely model responses 
occurring under physiological conditions, the application of 
tetramer-based technology has proved highly illuminating. 
During a polyclonal immune response, CD4+ T cells of various 
affinities for a given pMHCII are present in the immune repertoire; 
thus, it could be hypothesized from previous findings that those 
polyclonal cells with a high affinity for a specific pMHCII would 
preferentially differentiate into Th1 cells, whereas those with a 
lower affinity would differentiate into Th2 cells. To assess this 
possibility, Milner et al. (30) employed a tetramer-based staining 
system to deplete high-affinity CD4+ T cells and found that in the 
absence of such cells, stimulation of a polyclonal population with a 
specific pMHCII combination led to the preferential induction of 
a Th2 population, which was abrogated in the presence of higher 
affinity cells. These findings have been significantly extended by 
the use of an in  vivo limiting-dilution system, which assessed 
the role of clonal differences in TCR signaling in response to a 
specific Listeria monocytogenes (Lm) peptide (31). Here, it was 
determined that single polyclonal cells responding to the Lm pep-
tide displayed widely divergent abilities to differentiate into Th1, 
Tfh, and germinal center (GC) Tfh cells. However, when averaged 
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together, these populations gave a characteristic pattern of dif-
ferentiation, indicating that the diverse behaviors of individual 
naive CD4+ T cells with differing affinities for a specific peptide 
are able to account for the consistent pattern of response, which is 
found in a responding population of CD4+ T cells under in vivo 
conditions (31). Additionally, this study also indicated that the 
differentiation of Th1, Tfh, and GC-Tfh cells during Lm infection 
was dose dependent, with low-dose Lm infections leading to the 
predominance of Th1 and Tfh cells and high-dose infections lead-
ing to a corresponding decrease in the proportion of Th1 cells and 
an increase in the proportion of Tfh cells, especially GC-Tfh cells. 
An in vivo comparison of CD4+ T cells responding to whole PCC 
protein immunization further showed that precursor T cells with 
a higher affinity for pMHCII preferentially differentiated into Tfh 
cells and that LN-resident Tfh cells displayed a restricted TCR 
repertoire and displayed stronger pMHCII binding, (32) reinforc-
ing the idea that Tfh cells are inducible in response to strong TCR 
signaling. Mechanistically, it has been shown that the generation 
of Tfh cells requires strong/sustained TCR signals through the 
analysis of the requirement for ITAM multiplicity in TCR signal-
ing during Tfh cell generation, where it was determined that the 
presence of mutant ITAMs lacking their p-Tyr residues decreased 
proximal signaling downstream from the TCR and led to a 
concomitant decrease in Tfh cell generation (33). In vivo studies 
using 2P imaging to study the dynamic components of both B–T 
(34) and DC–T (35) interactions during Tfh cell responses have 
demonstrated that Tfh cells most frequently interact with APCs 
presenting strong pMHCII signaling complements and that pro-
longed Ag presentation was required (≥72 h) in order to most 
efficiently induce Tfh cell differentiation (36, 37). Together, these 
data indicate that very strong TCR stimuli are associated with 
the continued interaction of DC and CD4+ T cells for extended 
periods of time and that these ongoing interactions are required 
for Tfh cell differentiation.
Th17 differentiation has also been observed to occur in a dose-
dependent manner; initial studies indicated that in  vitro Th17 
differentiation occurs in response to stimulation with a strong 
pMHCII stimulus, in conjunction with the presence of exogenous 
TGFβ and IL-6. Here, it was found that high doses of antigen 
were able to upregulate CD40L, and in combination with specific 
adjuvants, this increased DC IL-6 production leading to the dif-
ferentiation of Th17 cells under in vitro and in vivo conditions 
(38). Interestingly, in the presence of IL-6 and TGFβ, the ability 
of naive CD4+ T cells to differentiate into Th1 or Th2 cells was 
abrogated, but Th17 differentiation was found to correlate with 
the strength of antigenic stimuli. CD4+ T cells deficient for Itk, a 
tyrosine kinase activated as part of the proximal response to TCR 
activation, have additionally been shown to have a decreased 
TCR-induced Ca2+ flux response (39) to antigen and have a 
deficiency in Th17 differentiation, even in the presence of IL-6 
and TGFβ (40). Conversely, Itk-deficient cells exhibited increased 
Treg cell differentiation under Th17 conditions, where cells were 
found to be more sensitive to IL-2 signaling while exhibiting an 
activation profile similar to that observed in cells activated with 
a weak TCR stimulus (41). This observation indicates that Treg 
and Th17 differentiation may result from stimulation under a 
similar cytokine milieu, but their alternate induction is driven 
by TCR stimulation at opposite ends of the activation spectrum. 
Together, this literature clearly indicates that the predominant 
thesis describing CD4+ T cell differentiation by qualitative 
cytokine-based induction needs to be updated to better integrate 
the wealth of studies demonstrating a significant role for quanti-
tative mechanisms in differentiation.
tCr siGnaL strenGtH inFLUenCes 
MeCHanisMs oF QUaLitatiVe 
siGnaLinG dUrinG diFFerentiation
Naive CD4+ cells display an array of cytokine receptor mol-
ecules on their surfaces, such as IL-4R, IL-6R, IL-17R, IFNγR, 
and TGFβR, which are important for the induction of multiple 
differentiation programs. However, upon TCR activation, the 
expression of additional cytokine receptors such as the high-
affinity IL-2R (CD25) (42) and the IL-12Rβ2 (43) is induced, and 
levels of existing cytokine receptors may be modulated according 
to signal strength (44). Interestingly, cytokines, such as IL-12 (45) 
and IFNγ (46, 47), associated with Th1 differentiation, have been 
shown to require the formation of mature immune synapses (IS) 
for their efficient delivery, with cytokine receptors localizing to 
the IS following formation of a mature IS, whereas IL-4 associated 
with Th1 differentiation (12), but not necessary for Th2 differen-
tiation (14), is thought to act in a paracrine fashion, as does IL-2. 
Accordingly, these cytokines are not secreted in a directional 
fashion and their receptors do not display polarization even upon 
formation of a mature IS (47, 48).
However, responsiveness to IL-2 signaling has been shown 
to be regulated by TCR signal strength; activation by both weak 
and strong stimuli leads to an increased expression of IL-2R, but 
strong stimuli also cause an attenuated ability to signal via IL-2R 
through inhibition of phosphorylation of the transcription factor 
STAT5 (24), induced by the dose-dependent repression of Pten 
(41). The dose-dependent control of IL-2 signaling may therefore 
be a major factor controlling the Treg–Th17 differentiation axis. 
As where Th1 and Th2 differentiation is inhibited by TGFβ, Treg 
and Th17 differentiation predominates (38, 41, 49). However, 
while IL-2 is essential for Treg differentiation (18), IL-2 signal-
ing inhibits Th17 differentiation (50); therefore, the negative 
feedback on STAT5 phosphorylation induced by strong TCR 
signaling allows for Th17 differentiation in the presence of IL-2, 
similar to that produced by naive T cells at early time points after 
activation. Further, Th17 differentiation has been shown to be 
dependent on the production of IL-6 by DC; thus, the potential 
exists that Th17 induction may require high levels of TCR stimuli 
in order to form a mature IS to allow for the directional secretion 
of IL-6. Though the directionality of IL-6 secretion at the T–DC 
interface has not been fully investigated, IL-6 is thought to be 
synaptically secreted in the central nervous system (51). The 
repression of IL-2R signaling may also play a significant role in 
the differentiation of the Tfh cell lineage. Upregulation of Bcl-6 is 
required for Tfh cell commitment, as opposed to the expression of 
Blimp-1, which is expressed by T effector lineages (52). Blimp-1 
is upregulated in naive T cells upon activation and exposure to 
IL-2 (53) and causes the inhibition of Bcl-6 expression repressing 
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Tfh cell differentiation in a STAT5-dependent manner (54). 
Additionally, the anti-apoptotic qualities of Bcl-6 may serve a 
protective function during Tfh cell differentiation (55) by allow-
ing their stimulation by the very strong TCR signals over a long 
period of time that are required for Tfh cell differentiation, while 
avoiding activation-induced cell death (AICD).
In terms of Th1 differentiation, we recently showed that 
under both in vitro and in vivo conditions, TCR signal strength 
controlled downstream IL-12 receptor expression, with IL-12Rβ2 
directly correlating with signal strength. Linking TCR signaling 
to the ability of CD4+ T cells to respond to cytokine signaling and 
establishing TCR-induced signaling play a dominant role in the 
signaling hierarchy (27). Together, these data indicate that CD4+ 
T cells display an ability to quantitate and integrate signals from 
the TCR and co-stimulatory molecules, which then regulates 
both the length of interaction and downstream checkpoints, such 
as the upregulation of cytokine receptors and their polarization 
to the IS, which is required for the cytokine-mediated control of 
effector differentiation. As the strength of signal received through 
TCR can alter the interaction time between T cells and DC, this 
indicates that it is an integral component in determining the 
outcome of differentiation.
a teMporaL interaCtion-Based 
ModeL to desCriBe tCr-driVen 
diFFerentiation IN VIVO
In Vivo Modeling of t Cell Migration
T cells display a default scanning behavior under in vivo conditions 
possessing what could be thought of as an inbuilt “migrational 
momentum,” such that they will resist activatory “Stop” signals 
from an APC, unless a significant influence is exerted upon them. 
Multiple studies (26, 27, 34, 56) have shown a high degree of cor-
relation between the length of time T cells interact with APCs and 
the outcome of differentiation, suggesting the need for a model 
of differentiation that takes into account the dynamic nature of 
T cell–DC interactions, the role of TCR in facilitating the nature 
of these interactions, and the pattern of resultant downstream 
signaling that regulates the outcome of differentiation.
T cells display a natural propensity for migration, with naive 
T cells estimated to recirculate though the secondary lymphoid 
organs in as little as a few hours as they search for cognate antigen 
(57, 58). Initial imaging studies (59, 60) assessing the behavior of 
naive CD4+ T cells in lymph node explant models characterized 
a short-lived contact duration between naive T cells and APCs of 
approximately 3 min. These Ag nonspecific interactions did not 
lead to T cell activation and were followed by a rapid dissociation 
and migration away from the APC, allowing the naive T cell to 
continue its scanning behavior. It was further noted that apart 
from brief pauses, naive T cells exist in a state of constant kinesis 
(61). The apparent random nature of in vivo migratory behavior 
observed in early studies led to the adoption of a random walk 
model, with T cells migrating as autonomous agents taking inde-
pendent and stochastic paths through the secondary lymphoid 
tissue in search of APCs with cognate Ag (60, 61). However, more 
detailed studies examining the structure of secondary lymphoid 
organs characterized a complex matrix-like environment consist-
ing of a network of interconnected follicular reticular cells along 
which T cells and APCs traffic (62). A particularly dense network 
of FRCs is associated near the HEVs in the paracortex, which 
enables the localization of tissue-derived DCs for the efficient 
presentation of Ag to immigrating T cells, and upon Ag adminis-
tration, this site corresponds to areas of T cell clustering and early 
activation (63, 64). The expression of CCR7 by naive T cells and 
its requirement for migration into the lymphoid compartment is 
well documented (64, 65). However, the role it plays in guiding 
CD4+ T cells once inside the SLOs is less clear. FRCs in both 
humans and mice produce the CCR7 ligands CCL19 and CCL21 
(66, 67) and likely guide the migration of naive CD4+ cells under 
steady-state conditions (67, 68). Upon inflammation, the potential 
role of chemokine gradients is yet to be fully determined, though 
activated dendritic cells have been observed to secrete CCL19 
(69) and CCL21, and the expression can be downregulated by 
FRCs during an immune response (70). Ligation of CCR7 by 
CCL19 leads to receptor phosphorylation and internalization and 
a subsequent desensitization, potentially providing a mechanism 
for local CD4+ guidance, whereas CCL21 binding does not 
exhibit a reciprocal effect drawing naive CD4+ T cells toward 
activated DCs. The blockade (68) or disruption (71) of CCR7 
ligand signaling has been shown to reduce the velocity of CD4+ 
migration, but failed to completely abrogate migration, indicating 
either the presence of additional as yet unidentified ligands or 
that CD4+ T cells exhibit a constitutively migrant behavior under 
in vivo conditions.
tHe initiaL aCtiVatory siGnaL 
proVided By KinetiC sCreeninG 
aLLoWs prooFreadinG/VaLidation 
oF CorreCt pMHC:tCr MatCHinG
Upon interaction with APCs, it is vital for T cells to strictly dis-
criminate between self and non-self ligands to avoid autoimmune 
disease, while at the same time maintain tolerance to nonpatho-
genic environmental antigens to avoid unnecessary pathology. 
In vitro studies have demonstrated that CD4+ T cells can be 
activated by less than ten cognate peptides presented by an APC 
in the presence of MHCII (72, 73); thus, T cell responses exhibit 
a very high degree of sensitivity. In order to scan the maximal 
number of APCs, non-productive interactions must be quickly 
terminated, such that in the absence of response to an agonist 
peptide, CD4+ T cell:APC interactions have been estimated to 
last between 1 and 5 min (59, 61, 74) and up to 5,000 T cells may 
contact and scan a single DC during an hour (74). The transition 
from TCR binding to signaling is highly specific, resulting in the 
ability to integrate TCR:pMHC interactions, which occur over a 
minimal range of Kd into a definitive digital on/off recognition 
signal (75). Thus, on the one hand, T cells must be able to rapidly 
and efficiently recognize their cognate Ag and, on the other, must 
display a rigorous intolerance to activation via the myriad of self-
peptide and environmental antigens displayed by APCs.
In order to account for many of the observed details of TCR 
signaling and CD4+ activation, a kinetic thresholding with 
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differential signaling feedback model of ligand discrimination 
has been suggested, (76) in particular, this mechanism of TCR 
signaling accounts for the speed, sensitivity, and specificity of 
signal discrimination. Kinetic thresholding models dictate 
that following pMHC:TCR interaction, proofreading kinases 
associated with the CD3 components of TCR phosphorylate the 
multiple tyrosine residues contained in the CD3 ITAM regions, 
allowing ZAP-70 association and progression of downstream 
signaling. Upon pMHC:TCR dissociation, the ITAMs are then 
dephosphorylated by constitutively active phosphatases, thereby 
attenuating the progression of signaling from the TCR. Thus, 
the duration of pMHC:TCR interaction sets the level of ITAM 
phosphorylation, which controls the lifetime of downstream 
signaling with the utilization of multiple proofreading kinases, 
allowing for the amplification of signaling in a nonlinear fashion 
(77–79). However, the initial kinetic proofreading models do not 
sufficiently account for all the characteristics of CD4+ activation; 
thus, in order to extend these models, an additional differential 
feedback step as identified by Stefanova et al. (80) was included. 
Here, Erk and SHP-1 were identified as key components of signal 
discrimination during the kinetic proofreading process. Following 
TCR engagement by both antagonistic and agonistic ligands, Lck 
is activated, resulting in its association and phosphorylation of 
both ZAP-70 and ITAMs, and Lck additionally phosphorylates 
the regulatory phosphatase SHP-1. In the case of TCR associa-
tion by antagonistic or weak ligands, phosphorylation of SHP-1 
allows binding to and inactivation of Lck and further enables a 
close association of SHP-1 with ZAP-70 and ITAMs, potentially 
resulting in the dephosphorylation of unprotected residues and 
cessation of signaling. However, following association with a 
strong agonist pMHC, the MAP kinase ERK is rapidly activated 
and phosphorylates Lck at Ser59, inhibiting the binding of SHP-1 
and the subsequent inhibition of Lck kinase activity. Thus, ERK 
activation by strong agonists acts at a local level to protect Lck 
activity at TCR associated with agonist activation, causing the 
stabilization of ITAM phosphorylation and preventing desen-
sitization through the subsequent binding of pSHP-1, which 
also accumulates following strong agonist binding. Under this 
model of TCR activation, signaling occurs in a binary fashion, 
with pSHP-1 inhibiting the activation unless threshold levels of 
agonist pMHC are encountered, whereupon, the system shifts 
to a fully activated state with full Erk phosphorylation, ZAP-70 
activation, and phosphorylation of ITAMs.
Initial recognition of a pMHC:TCR match is amplified by 
Lck activation and phosphorylation of ZAP70, decreasing the 
activation threshold on neighboring TCR allowing for signal 
spreading by activation through interaction with lower affinity 
(self)pMHC:TCR interactions, which would be agonistic under 
steady-state conditions. It has been proposed that once activated 
ERK (76, 80) and/or Lck can act in a trans fashion, exerting effects 
on neighboring TCR to reduce the kinetic threshold of pMHC-
TCR lifetime required for activation. Here, the transactivity of 
ERK and/or Lck may lead to a localized alteration in the balance 
of ITAM kinase vs. phosphatase activity, such that the speed of full 
ITAM phosphorylation occurs more rapidly than the dissociation 
of the pMHC:TCR complex, thereby causing TCR activation and 
recruitment of ZAP-70 in response to weak agonistic ligands such 
as self-peptides (81), resulting in a signal spreading mechanism 
and the formation of a local microcluster, which allows for the 
induction of TCR signaling from a small number of strong ligands. 
However, it is debatable whether this gives a better account for the 
stoichiometry of TCR downregulation than previously proposed 
models that envisage a serial engagement of pMHC by TCR with 
fast kinetics to account for the sustained signaling observed (82, 
83). Additionally, signal spreading may provide a mechanism for 
the downstream calculation of TCR signal strength that cannot be 
accounted for by a binary mechanism of TCR activation.
pMHC:tCr siGnaLinG indUCes 
MULtipLe doWnstreaM patHWays 
WitH distinCt eFFeCts on tHe 
dUration oF interaCtions and tHe 
oUtCoMe oF diFFerentiation
Each successful pMHC:TCR interaction induces at least two 
major distinct pathways; the first pathway leads to the induction 
of a default activation program consisting of proximal MAPK 
phosphorylation and the second results in an increase of intracel-
lular Ca2 + (Figure 2A). In lymphoid organs, the initial phase of T 
cell:APC interactions has been observed to comprise a number of 
brief serial interactions, with CD4+ T cell interactions lasting an 
average of 11–12 min (60) and CD8+ T cell interactions lasting 
5–6 min (84). However, the average velocity of T cells decreases 
after contacting APCs loaded with cognate peptides during this 
first phase of interaction, and transient increases in intracellular 
calcium levels are observed (85). The sustained level of interac-
tion necessary to form a mature IS does not generally occur until 
later in the response. However, following the kinaptic recogni-
tion (86) of cognate pMHC, T cells may receive a stimulatory 
signal sufficient to induce activation and maturation (87, 88). 
We propose that this indicates that in the absence of a sustained 
increase in calcium signaling sufficient to facilitate a halt in T 
cell migration required for the formation of a mature IS, what 
could be considered a default “on” pathway is sufficient to initiate 
TCR-driven activation of downstream transcription factors (89, 
90). Thus, signaling from the TCR is able to directly turn naive T 
cells “on” and initiate maturation and differentiation by a primary 
default mechanism following the discrimination of a positive 
TCR signal. Second, where a sufficiently strong TCR signal is 
received, this may cause a halt in T cell migration by mediating 
a sustained increase in the intracellular calcium, thus allowing 
the formation of the IS and a prolonged T cell:APC interaction 
(91), as required for Th1 differentiation. The ability of T cells 
to discriminate between APCs loaded with different activatory 
stimuli allows T cells to perform a calculus when deciding which 
DC to form a synaptic relationship with (56) and indicates that T 
cells have specific mechanisms for determining the quantity and 
quality of signal they are receiving, which in turn imparts specific 
effector information.
While T cells are able to calculate the level of signal imparted 
to them by a specific APC, a mechanism for this has not yet been 
fully ascertained. However, it is known that naive T cells are able 
to form a stable long-lasting IS within minutes when forced to 
FiGUre 2 | Length of interaction alters the activation of specific transcription factors. (a) Schematic diagram denoting the major signaling molecules 
involved in the T cell activation process upon stimulation of the TCR by cognate pMHCII, leading to the differential activation of downstream transcription factors 
based on signal strength and interaction times. (B) Short-term interactions induce a subset of default pathway of fast-acting transcription factors, which 
preferentially activate Th2-associated genes. Interaction for a longer period of time induces both default pathway-associated transcription factors and additionally 
allows for the induction of Th1-specific transcription factor activation, which are able to override the default Th2-inducing signal and skew the response toward the 
differentiation of a Th1 subset.
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interact with lipid bilayers or APCs in culture, indicating that de 
novo protein synthesis is not a prerequisite for IS formation (92). 
In vivo, T cells have been observed to progress through an initial 
priming phase (phase I) of activation where APC encounters 
consist of brief serial contacts, before transitioning to phase II 
where long-lasting contacts with APCs are maintained (60, 93). 
However, this initial priming phase does not seem to be required 
for induction of full T cell activation as following in vitro activa-
tion T cells may proceed directly to phase II with the formation 
of an IS. It is possible that in vivo, the priming phase is used as 
a mechanism to calculate the level of pMHC being presented, 
leading to a decision whether to form an IS, while under in vitro 
conditions, the pMHC concentrations used to study IS formation 
are sufficient to bypass phase I. Alternatively, as the physiological 
signals that normally drive naive T cell migration are not present 
in  vitro, this may lead to a reduction in cellular momentum 
and thus a decreased requirement for a brake-inducing signal. 
To account for the observed T cell behavior, such a stopping 
mechanism must be both quantitative for pMHC encountered 
and iterative with each APC interaction. One possibility for such 
an integrative function is the IP3-mediated release of intracellular 
Ca2+, whereby receptor signal spreading leads to an exponential 
increase in the quantity of TCR signaling complexes available to 
recruit and activate PLCγ causing a concomitant increase in IP3 
production and signal strength-dependent release of Ca2+ from 
the ER. Huse et  al. (94) observed that activation at decreased 
[pMHC] levels or blocking of CD4 binding increased the offset 
time for Ca2+ release, which suggests that a threshold level of IP3 
is required for Ca2+ flux. Additionally, it has been demonstrated 
that in vivo activation of naive T cells with a low potency APL 
can induce upregulation of CD69 expression without inducing 
a sustained Ca2+ release, indicating the ability of T cells to be 
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activated in the absence of sufficient TCR signaling to trigger 
Ca2+ release (85).
Once threshold levels of intra-ER Ca2+ are reached, store-
operated calcium entry is then triggered via activation of STIM1 
and STIM2, which sense Ca2+ release via low-affinity Ca2+-
binding EF hand domains located in the ER lumen. Translocation 
of STIM molecules to the plasma membrane causes opening of 
CRAC channels, a sustained increase in intracellular Ca2+ levels, 
and initiation of a cellular brake response allowing for IS forma-
tion (32), as opposed to a brief kinaptic interaction. Initially, T cell 
momentum dictates the overall length of T cell:APC interaction, 
as Ca2+ levels must reach the threshold for CRAC channel activa-
tion within a predetermined period of time in order to induce a 
T cell braking response; otherwise, migration will continue. As 
in the absence of CRAC opening, the T cell fails to arrest, and the 
kinaptic interaction will be broken, with ER Ca2+ slowly returning 
to baseline, such that, ER Ca2+ levels may form an intracellular 
clock based on Ca2+ reuptake vs. [pMHC] stimulation.
Several studies (73, 85, 90, 95) have reported the correlation 
between the arrest of naive T cell migration and an increase 
in Ca2+ signaling following encounter with APC, although a 
mechanism for this decreased motility has not been completely 
described (86, 89, 96, 97). What is evident from this body of 
work is that the spike in intracellular Ca2+ levels following TCR-
induced CRAC opening marks the transition from a migratory 
phase to a primary signaling phase, which may better account for 
the T cell ability to quantitate [pMHC]. It has been reported (98) 
that following TCR activation, WASp-deficient T cells displayed 
normal IS formation initially; however, after further migration, 
WASp-deficient T cells were unable to reform a stable IS in the 
presence of PKCθ. Conversely, PKCθ-deficient T cells formed 
hyper-stable IS and displayed impaired migratory ability. Sims 
et al. (98) suggest that PKCθ is required for the periodic break-
ing of IS symmetry, which allows for bursts of mobility during 
phase I of activation, with WASp playing an opposing role in 
re-establishing symmetry upon encounter with subsequent 
APCs. Thus, the interplay between PKCθ and WASp provides 
a mechanism for the quantitation of [pMHC]. Large increases 
in intracellular [Ca2+] are associated with a decrease in T cell 
motility, with Ca2+ flux signaling initiating the reorganization of 
f-actin function, from providing the mechanical force necessary 
for migration (99) to one whereby f-actin stabilizes the IS (89). 
F-actin clustering is additionally required to stabilize activated 
LFA-1 at the cell surface (96); thus, f-actin-stabilized LFA-1 per-
sistence at the cell surface may represent a further downstream 
mechanism for determination of antigen signal strength and 
may link PKCθ/WASp activity to the transition between phase 
I/phase II T cell migratory behavior. Additionally, the ER/CRAC 
channel circuit in T cell displays capacitor-like behavior, with 
the ability to rapidly evoke a significant increase in the intracel-
lular Ca2+ level followed by a period of heightened intracellular 
[Ca2+] as Ca2+ ions are removed by specific pumps. At this time, 
the IP3R is unresponsive to further signaling as bound Ca2+ on 
the cytosolic side of the ER inhibits IP3 binding (100). During 
this period, the TCR-associated activation of WASp may organ-
ize f-actin stabilization of LFA-1 (and other integrins) at the 
kinaptic interface in response to pMHC levels, whereas upon 
decrease of Ca2+ to sufficient levels, PKCθ activity induces a 
redirection of f-actin polarization away from the T cell–APC 
interface, destabilizing the connection and allowing the resump-
tion of migration.
Studies have shown that LFA-1 is required for optimal in vivo 
priming (101) and that LFA-1 decreases the antigen dose required 
for Th1 differentiation (102). Thus, an increase in activated LFA-1 
at the cell surface may serve as a molecular counter for previous 
TCR:pMHC interactions, whereby upon the cumulative activa-
tion of sufficient LFA-1, the rate of polymerization of f-actin at the 
T cell:APC interface is greater than the PKCθ-induced migration-
associated f-actin polymerization, enabling maintenance of the 
kynapse long enough for the ER to refill and induce recurrent 
calcium spiking. In turn, inhibiting PKCθ-induced migration for 
a sufficient period of time allows for the formation of a mature 
IS. Mechanistically, this provides an explanation for previous data 
indicating that the transcription of Ca2+-associated gene targets is 
more efficiently activated by oscillating calcium levels rather than 
a sustained increase in Ca2+ levels (91, 103, 104).
a Case stUdy in teMporaLLy 
reGULated diFFerentiation: th1 Vs. 
th2 indUCtion
induction of sustained signaling through 
is Formation promotes a program of 
differentiation Favoring th1 development
It is now well established that the stimulation of naive CD4+ T 
cells with a strong agonist or high dose of peptide leads to the 
induction of Th1 differentiation, while low dose or weak APL 
stimulation leads to the induction of Th2 differentiation (19, 21, 
22, 24, 105). However, a molecular mechanism to explain these 
phenomena has not yet been adequately provided. Much of the 
data generated on the induction of Th1 differentiation have indi-
cated that the required signal may be imparted through the for-
mation of a mature IS. Knockout studies have revealed that many 
of the components, which link TCR activation with IS formation 
such as the calcium signaling (106–108) and actin polarization 
pathways (109, 110), are also required for Th1 differentiation. 
Thus, it is possible that transcription factors, which are regulated 
proximally to TCR signaling, are regulated in a temporal fashion, 
whereby long-term activation is required for the optimal activa-
tion and function of Th1-associated transcription factors such 
as Jun Kinase (JNK) (22), Erk1/2 (22, 24), AP-1 (fos:jun) (22), 
NFAT-1, and NFAT-4 (21). Several possible mechanisms exist 
that may account for the requirement for long-term signaling; 
Th1-associated transcription factors may take longer time to be 
phosphorylated and translocate to the nucleus, as suggested by 
Brogdon et al. (21) where a weak TCR stimulus caused transloca-
tion of NFAT-2 to the nucleus and a strong stimulation led to the 
nuclear recruitment of both NFAT-2 and NFAT-1. Alternately, 
Th1-associated gene targets may be more inaccessible, requiring 
greater alterations to their methylation and acetylation states 
before transcription is possible. Third, Th1-associated transcrip-
tion factors may be subject to a greater degree of regulation by 
inhibitory kinases or phosphatases after activation, leading to 
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a diminished half-life, comparatively decreasing their ability to 
localize to the nucleus and hence their signaling capacity.
sHort-LiVed interaCtions Lead to 
tHe initiation oF a deFaULt/
endoGenoUs aCtiVation proGraM 
LeadinG to th2 diFFerentiation
In addition to low-dose/affinity peptide stimulation inducing 
Th2 differentiation, alterations to the TCR-associated signaling 
machinery can lead to the induction of Th2 differentiation. 
Inhibition of ZAP70 (111), a proximal TCR-associated kinase, 
which associates with phospho-ζ, was found to cause Th2 skew-
ing, and a point mutation in the ZAP70 kinase domain has been 
described, which additionally induces Th2 skewing (112). As 
ZAP70 is thought to be required for full activation and efficient 
signaling, abrogation of its function is likely to lead to a decrease 
in the transduced signal strength and corresponding calcium 
flux, thus interfering with the ability of the cells to arrest and form 
a mature IS. Further, defects in LAT, which is phosphorylated 
by ZAP70 and is thought to act as a negative regulator of TCR 
signaling, have been described, whereby animals developed lym-
phoproliferative disorders with pronounced Th2 skewing (113). 
Here, it is likely that in the absence of sufficient negative regula-
tion, weak signals are sufficient to activate cells but insufficient 
to induce full calcium flux and migratory arrest, thus leading to 
short-lived interactions and Th2 differentiation.
Th2-associated signaling has also been observed to be more 
dependent on activation of co-stimulatory pathways with defects 
in CD4 (23), CD28 (114), Lck (21), and PI3K (115), causing 
deficiencies in Th2 differentiation. As such, it is possible that as 
decreased overall signal strength is associated with Th2 induc-
tion, differentiation may be more highly reliant on co-stimulation 
in order to drive productive signaling, whereby signals that would 
not usually reach the threshold for activation or those that would 
lead to an anergic response can be modulated by effects of co-
stimulatory receptor activation through Lck and its downstream 
effects on Zap70 induction, leading to a productive TCR engage-
ment. Additionally, co-stimulatory signals lead to the preferential 
induction of the Th2-associated transcription factor NFκB1 (116, 
117), through a pathway that requires PKCθ and IKKα signaling 
(118, 119). Thus, the reliance of Th2 induction on co-stimulation 
may play two roles whereby it serves to both ensure the transduc-
tion of weak TCR signaling in the presence of a strong danger 
signal and lead to the induction of Th2 differentiation via a 
default NFκB1-driven pathway in the absence of Th1 promoting 
transcription factors.
Other transcription factors known to affect differentiation 
include the AP1 binding elements fos:jun and jun:jun, which 
induce Th1 and Th2 differentiation, respectively (1, 22). While 
jun:jun homodimers are sufficient to bind DNA elements, jun:fos 
heterodimers are more energetically stable and thus have higher 
binding efficiency and target affinity, allowing binding to a wider 
range of targets (120, 121). However, the efficiency of dimer 
formation is temporally controlled through the regulation of 
p38 and Erk, which activate fos and JNK and then jun (120). 
p38, Erk, and JNK are cytosolic proteins that require phospho-
rylation by upstream kinases in order to migrate to the nucleus 
and are also subject to heavy regulation by phosphatases. Upon 
nuclear entry, this sets up a highly dynamic situation whereby 
variations in the phosphorylation: dephosphorylation rates of 
p38, Erk, and JNK lead to differential nuclear ratios of active fos 
and jun (122). The temporal model put forward here predicts 
that short-term signaling would lead to high levels of active 
jun and Th2 induction, whereas nuclear localization of p38 and 
Erk would occur later, increasing active fos levels and favoring 
jun:fos formation and Th1 induction. In support of this theory, 
it has been previously reported that Erk signaling is maximal 
at both high peptide doses (24) and where strong agonists 
are used (22), whereas low peptide doses and weak agonists 
induced low levels of Erk activation (24). Further, where weak 
agonists were used or Erk was inhibited, jun:jun homodimer 
formation was found to far exceed that of fos:jun formation 
and was also associated with early production of IL-4 (22). 
This indicates that strong TCR signals, which also induce long-
term interactions, are required for full Erk activation, fos:jun 
formation, and Th1 induction, where as weak signals induce 
short-term interactions and jun:jun formation, favoring Th2 
differentiation (Figure 2B).
sUMMary
Here, a temporally based mechanism of differentiation is 
suggested that accounts for many of the observed aspects of 
strength of signal-induced differentiation and the downstream 
signaling pathways associated with Th1 and Th2 differentiation. 
In this model, long-term interactions induce a program of Th1 
differentiation and short-term interactions induce a program 
of Th2 differentiation. Integrating TCR signal strength through 
downstream signaling machinery such as calcium release allows 
for the influence of additional signaling systems such as co-
stimulatory molecule activation and potentially cytokine signals 
to be combined to dictate the length of interaction between DC 
and CD4+ T cells and thus contributes to downstream effector 
differentiation (27). By varying the length of interaction time, 
cell fate is able to be controlled through utilizing the activation 
potentials of both fast-acting transcription factors such as NFAT2 
and jun:jun and slow-acting transcription factors such as NFAT1 
and fos:jun, with shorter interactions favoring Th2 induction and 
longer interactions Th1 induction. As these transcription factors 
are tightly regulated by both kinases and phosphatases, differen-
tiation requires an interplay between the cycling of transcription 
factors between inactive/cytosolic and active/nuclear states, such 
that threshold concentrations of localized activated factors may 
be required in order to mediate the formation of epigenetic modi-
fications and the switching on or off of the genes that control both 
differentiation state and effector function (3). As such, this level 
of control would allow for tightly regulated molecular signaling 
events to be transduced in a global fashion through modulation 
of multiple transcription factors by a temporal mechanism.
From a biological point of view, this temporal model helps 
explain several phenomena. As interaction time is relative to 
total signal strength, a model where marginal signaling such as 
January 2016 | Volume 7 | Article 610
van Panhuys T-DC Interactions and Differentiation
Frontiers in Immunology | www.frontiersin.org
engagement of only a few pMHC or use of very weak APL or 
 activation in the absence of co-stimulation leads to the induction of 
an anergic program, and weak signaling induces Th2  differentiation 
and strong signaling causes Th1 induction. This provides a poten-
tial explanation for how tolerance to environmental antigens is 
induced, how the immune system detects a parasitic infection, 
and how environmental allergens induce Th2-associated allergic 
disease, whereas self-antigen recognition leads to Th1-associated 
autoimmune disease. Tolerance to common environmental anti-
gens is generally induced as a normal response to the presentation 
of low levels of antigen in the absence of co-stimulation and thus 
induces a weak TCR response and an anergic program due to 
abrogated signaling and interactions (123). Nematode parasites 
on the other hand represent a  significant pathogenic burden and 
secrete a large array of antigens as well as induce danger signals 
as they migrate through host tissue. Thus, in order to avoid host 
responses, parasites secrete molecules that downregulate the 
function of APCs and, while undergoing maturation within the 
host, turn over their antigenic profile, in some cases multiple 
times, during the course of their lifecycle. As such, parasites only 
secrete a specific antigen for a limited time, thus decreasing host 
recognition (124, 125). Further, the amount of specific antigen 
taken up by an individual DC is likely to be very small due to the 
inability of DC to phagocytize parasites, forcing reliance on endo-
cytosis or pinocytosis for uptake of secreted Ag. Considering this, 
it is likely that as an evolutionary mechanism to combat nematode 
infection, the immune system has evolved to recognize parasites 
in terms of a moderate–to-low signal strength, which then allows 
for full activation via an endogenous pathway, in the absence of 
long-term signaling, which induces a program of differentiation 
culminating in a Th2 response. Similarly, when the immune sys-
tem is stimulated by common environmental allergens, which are 
often capable of inducing danger signals (126), there may be a fine 
balance between inducing anergy and inducing a Th2 response, 
such that in the case of an initial encounter with an allergen in suf-
ficient quantity or potency, a Th2 response may be induced, which 
when combined with chronic antigen exposure induces allergy. 
Conversely, autoimmune diseases tend to be predominantly Th1 
or Th17 associated (127), which may be due to the thymic condi-
tioning of the CD4+ repertoire through negative selection, such 
that CD4+ cells are generally non-reactive to self, except where a 
significant stimulus of sufficient quality is encountered (128). Such 
strong signaling may activate any cells remaining in the repertoire 
that are able to recognize self-antigen, and through recognition of 
a strong signal, a program of long-lasting interactions is induced 
leading to Th1or Th17  differentiation. During the induction of 
 autoimmunity, strong TCR signaling may potentially occur due to 
the availability of a large amount of peptide via extensive presenta-
tion of self Ag or in the case of significant damage, where normally 
immune-privileged peptides are exposed in  combination with 
a substantial danger signal. Evolutionarily, such signals are 
analogous to bacterial or viral infections, where a limited range of 
epitopes are presented during infection in high quantities along 
with the activation of specific PAMPs, leading to the delivery of 
high strength signals causing long-term interactions with DC and 
the induction of a Th1 response.
Incorporating a temporal component into our models of 
how CD4+ T cells interact with DC during Treg, Th17, and 
Tfh cell differentiation also allows for an explanation of some 
of the additional phenomena that have been reported to occur 
during differentiation, which are not fully explained by a purely 
qualitative model of cellular decision-making. A distinct parallel 
can be drawn between the differentiation of Th1–Th2 cells and 
Th17–Treg cells, with both Th1 and Th17 cells requiring a strong 
TCR signal and have been observed to interact for long periods 
of time with DC, whereas both Th2 and Treg cells require weak 
TCR signals and only interact for brief periods of time. Further, 
Th2 and Treg cells are able to differentiate either via endogenous 
signals or from cytokines that are secreted in a diffuse fashion, 
whereas Th1 and Th17 cells require additional cues that are deliv-
ered at the cellular synapse and require a strong and/or ongoing 
signal in order to regulate their ability to respond to the cytokines 
that direct their differentiation. Tfh cell differentiation has also 
been observed to have a temporal component with ongoing 
interactions being required for differentiation, and as such, it is 
appealing to hypothesize that their expression of Bcl-6 may allow 
for this ongoing interaction in a non-deleterious fashion, while 
they acquire additional interaction-based signals from DC in the 
form of factors such as ICOSL (52) and CD40L (38).
In summary, a temporal signaling model would explain how 
many of the observed alterations in TCR signaling modulate 
differentiation by linking TCR signal strength, co-stimulation, 
and cytokine inputs through a mechanism that allows for the 
integration of multiple signaling inputs into an overall measure 
of signal strength and outputs these as divergent programs of 
behavior during priming, which ultimately leads to alterations in 
cell fate and effector function.
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